论文部分内容阅读
对５３例缺血性心脏病用心生丹－Ｍ＿２治疗，进行疗效观察，并与复方丹参片、心痛定的疗效比较，结果表明：心生丹－Ｍ＿２疗效的显效率２２．６％，总有效率８４．９％，高于复方丹参片组的６２．５％，也高于心痛定组的６０．０％。心生丹－Ｍ＿２在消除、改善临床症状、体征、恢复心电图的改变，以及改善心功能诸方面，与后两者比较有非常显著性或显著性差异（Ｐ＜０．０１～０．０５）。且未见毒、副作用。认为心生丹－Ｍ＿２是治疗ＩＨＤ安全、有效的纯中药制剂。
The curative effect was observed in 53 cases of ischemic heart disease treated with Xindan-M 2 , and compared with the results of compound Danshen tablets and nifedipine. The results showed that the effective rate of Xinsheng Dan-M 2 was 22.6%. The efficiency was 84.9%, which was higher than the 62.5% of the compound Danshen tablet group and also higher than 60.0% of the Xintongding group. Xinshengdan-M 2 had significant or significant differences in the elimination, improvement of clinical symptoms and signs, restoration of ECG changes, and improvement of cardiac function (P<0.01 to 0.05). . And no toxic, side effects. It is believed that Xinshengdan-M2 is a safe and effective pure Chinese medicine preparation for the treatment of IHD.